The Fund Grade · free · no account needed
What grade does ARKG get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
ARK Genomic Revolution ETF
#498 of 500 graded active funds · growth · large segment peer group
The point · specialist footprint
ARKG puts less of its book behind proven specialists than 92% of graded funds.
● Bottom 20%
Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
You pay 0.75% a year for a F.
3 funds in the same segment carry an A. Members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
ARKG vs the Honor Roll · share card ↗Conviction exposure
1%
of the book in specialist-converged names
Late-stage weight
12.2%
of the book in Crowded or Fading names
Active share
99.2%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
ARKG ranks 498 out of 500 graded funds, an F grade, while charging 0.75% annually. Its biggest position, CRSP at 8.9% of the fund, is Fading, meaning specialists who know this trade best are walking away. There are early-stage positions in BEAM and ABSI, but the weight of specialist exits makes the overall picture hard to defend.
→ Watch CRSP closely: at 8.9% weight and Fading, it is the single largest drag as specialists exit that position.
→ Compare this F-grade fund against the 3 higher-graded peers in the same segment, and note a better-graded option exists within the ARK family itself.
Support leaving these positions
Same family, higher grade
Read from today's disclosed book. Evidence, not advice.